Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma

NCT04722575 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Cobimetinib 20 MG Oral Tablet
DRUG: Vemurafenib 240 Mg Oral Capsule
DRUG: Atezolizumab 1200 MG in 20 ML Injection

Sponsor

Fondazione Melanoma Onlus

Collaborators

[object Object]